An analysis by the British medical journal The Lancet of unpublished drug company studies done on children and teens who take antidepressants concludes that only one drug, fluoxetine (known also by the brand name Prozac), was not associated with negative outcomes for children with depression. Last year, Britain's Committee on Safety of Medicines prohibited the treatment of childhood depression with any antidepressant except fluoxetine. The U.S. Food and Drug Administration has not taken this action, though it has approved only fluoxetine for children. NPR's Joanne Silberner reports on whether the new analysis sheds more light on the controversy about these medications.
NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.